CN1086129C - Hepatitis restoration pill - Google Patents
Hepatitis restoration pill Download PDFInfo
- Publication number
- CN1086129C CN1086129C CN99100650A CN99100650A CN1086129C CN 1086129 C CN1086129 C CN 1086129C CN 99100650 A CN99100650 A CN 99100650A CN 99100650 A CN99100650 A CN 99100650A CN 1086129 C CN1086129 C CN 1086129C
- Authority
- CN
- China
- Prior art keywords
- hepatitis
- radix
- herba
- medicine
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000006454 hepatitis Diseases 0.000 title claims abstract description 32
- 231100000283 hepatitis Toxicity 0.000 title claims abstract description 30
- 239000006187 pill Substances 0.000 title claims abstract description 19
- 239000003814 drug Substances 0.000 claims abstract description 28
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 10
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 10
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 241000746375 Andrographis Species 0.000 claims abstract description 8
- 241000190633 Cordyceps Species 0.000 claims description 8
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 2
- 235000013312 flour Nutrition 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims 2
- 241000209140 Triticum Species 0.000 claims 1
- 235000021307 Triticum Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 11
- 229940079593 drug Drugs 0.000 abstract description 5
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 206010004542 Bezoar Diseases 0.000 abstract 1
- 244000025254 Cannabis sativa Species 0.000 abstract 1
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 abstract 1
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 abstract 1
- 241000233839 Commelina communis Species 0.000 abstract 1
- 240000002045 Guettarda speciosa Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 241001598107 Imperata Species 0.000 abstract 1
- 244000126155 Lycopus uniflorus Species 0.000 abstract 1
- 235000002280 Lycopus uniflorus Nutrition 0.000 abstract 1
- 241000157511 Oldenlandia Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 abstract 1
- 229910052603 melanterite Inorganic materials 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 description 6
- 101710142246 External core antigen Proteins 0.000 description 5
- 208000002672 hepatitis B Diseases 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 206010003445 Ascites Diseases 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000007159 enucleation Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 208000035474 group of disease Diseases 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a Chinese patent medicine for curing hepatitis, which relates to a hepatitis restoration pill and belongs to the medicine field. The present invention is mainly characterized in that the hepatitis restoration pill contains the medicines of oldenlandia, dandelion, lalang grass rhizome, bugleweed, common dayflower herb, common andrographis herb, finger citron, giant knotweed rhizome, liquorice roots, red sage roots, peach kernel, angelica, Chinese magnolivine fruit, aweto, milk vetch, Chinese data, notoginseng, ganoderma, bezoar, melanterite, etc. The present invention has the characteristics of good curative effect and high cure rate, and can be widely used for curing different hepatitis in clinic.
Description
The present invention relates to a kind of Chinese patent medicine one hepatitis restoration pill for the treatment of hepatitis, belong to field of medicaments.
Hepatitis, the sickness rate height is one group of disease of serious harm human health.At present, the medicine of treatment hepatitis is a lot, waits bitterly for as interferon, anti-hepatitis B ribonucleic acid, the arabinose gland of Western medicine, and curative effect is low, easily recurrence, and toxic and side effects is big, costs an arm and a leg.Treatment by Chinese herbs hepatitis report to some extent in recent years, but effect is undesirable, relevant by retrieval document and Gazette of Patent for Invention, and not seeing has the same or analogous report with the present invention.
The object of the present invention is to provide and a kind ofly can effectively treat multiple hepatitis, cure rate height, taking convenience, Chinese patent medicine one hepatitis restoration pill without any side effects.
The present invention finishes by following technical scheme:
Described hepatitis restoration pill, its characteristics are to contain in this medicine medicines such as Herba Hedyotidis Diffusae, Herba Taraxaci, Rhizoma Imperatae, Spica Prunellae, Herba Commelinae, Herba Andrographis, Fructus Citri Sarcodactylis, Rhizoma Polygoni Cuspidati, Radix Glycyrrhizae, Radix Salviae Miltiorrhizae, Semen Persicae, Radix Angelicae Sinensis, Fructus Schisandrae Chinensis, Cordyceps, the Radix Astragali, Fructus Jujubae, Radix Notoginseng, Ganoderma, Calculus Bovis, Melanteritum.
Hepatitis restoration pill of the present invention, it is characterized in that its component by weight ratio (in the crude drug parts by weight) be: Herba Hedyotidis Diffusae 10-30 part Herba Taraxaci 10-30 part Rhizoma Imperatae 10-30 part Spica Prunellae 10-20 part Herba Commelinae 15-30 part Herba Andrographis 6-20 part Fructus Citri Sarcodactylis 5-15 part Rhizoma Polygoni Cuspidati 10-30 part Radix Glycyrrhizae 2-10 part Radix Salviae Miltiorrhizae 9-15 part Semen Persicae 6-10 part Radix Angelicae Sinensis 5-10 part Fructus Schisandrae Chinensis 3-12 part Cordyceps 3-10 part Radix Astragali 10-20 part Fructus Jujubae 10-35 part Radix Notoginseng 2-5 part Ganoderma 1.5-3 part Calculus Bovis 0.15-0.5 part Melanteritum 5-20 part.
Further specify the present invention below in conjunction with embodiment, but be not limited only to this.
Optimum implementation of the present invention:
Embodiment one:
1, the component of medicine and weight proportion thereof (in gram) are:
Herba Hedyotidis Diffusae 12g Herba Taraxaci 15g Rhizoma Imperatae 15g Spica Prunellae 10g Herba Commelinae 15g Herba Andrographis 9g Fructus Citri Sarcodactylis 5g Rhizoma Polygoni Cuspidati 15g Radix Glycyrrhizae 5g Radix Salviae Miltiorrhizae 12g Semen Persicae 6g Radix Angelicae Sinensis 9g Fructus Schisandrae Chinensis 3g Cordyceps 4g Radix Astragali 10g Fructus Jujubae 30g Radix Notoginseng 3g Ganoderma 2g Calculus Bovis 0.2g Melanteritum 10g
2, manufacture method:
With Herba Hedyotidis Diffusae; Herba Taraxaci; Rhizoma Imperatae; Spica Prunellae etc. 12 flavor Chinese medicines add that water is dense to be fried in shallow oil; mix twice fried liquid concentrated; get the dense juice A that fries in shallow oil; get Calculus Bovis; Radix Notoginseng; the Radix Astragali; Cordyceps; Radix Notoginseng; Ganoderma; Melanteritum 7 flavor Chinese medicine oven dry; be ground into fine powder B; to get and densely fry in shallow oil juice A and fine powder B stirs; be ground into superfine powder C after the oven dry, cross 100 mesh sieves and make powder D, the Fructus Jujubae water proof cooks the enucleation skin; smash into mud; with powder D mixing and stirring, sterile-processed after, make granular pill with granulating machine; the heavy 0.25g of every ball, patent medicine hepatitis restoration pill of the present invention.Certainly, those skilled in the art can be made for dosage forms such as pill, powder, sublimed preparation or capsule by the component of this Chinese patent medicine-hepatitis restoration pill, make things convenient for the patient to take.
3, drug administration method and preservation
For oral administration after meal, day clothes three times, each 0.25g～0.5g, 30 is a course of treatment, serve on 1～3 course of treatment.Medicine should place shady and cool dry place to preserve.
Embodiment two:
1, the component of medicine and weight proportion thereof (in gram) are:
Herba Hedyotidis Diffusae 15g Herba Taraxaci 15g Rhizoma Imperatae 20g Spica Prunellae 15g
Herba Commelinae 20g Herba Andrographis 12g Fructus Citri Sarcodactylis 10g Rhizoma Polygoni Cuspidati 20g
Radix Glycyrrhizae 5g Radix Salviae Miltiorrhizae 12g Semen Persicae 9g Radix Angelicae Sinensis 12g
Fructus Schisandrae Chinensis 9g Cordyceps 5g Radix Astragali 15g Fructus Jujubae 20g
Radix Notoginseng 3g Ganoderma 2g Calculus Bovis 0.3g Melanteritum 15g
2, the manufacture method of medicine, instructions of taking and store method are with embodiment one.
Embodiment three:
1, the component of medicine and weight proportion thereof (in gram) are:
Herba Hedyotidis Diffusae 30g Herba Taraxaci 30g Rhizoma Imperatae 30g Spica Prunellae 20g
Herba Commelinae 30g Herba Andrographis 20g Fructus Citri Sarcodactylis 15g Rhizoma Polygoni Cuspidati 30g
Radix Glycyrrhizae 10g Radix Salviae Miltiorrhizae 15g Semen Persicae 10g Radix Angelicae Sinensis 16g
Fructus Schisandrae Chinensis 12g Cordyceps 10g Radix Astragali 20g Fructus Jujubae 35g
Radix Notoginseng 5g Ganoderma 3g Calculus Bovis 0.5g Melanteritum 20g
2, the manufacture method of medicine, instructions of taking and store method are with embodiment one.
Above-mentioned three embodiment institute differences are to select according to the different state of an illness of patient, and the parts by weight that each medicine of distinguishing the flavor of is got differ, and make the stronger hepatitis restoration pill of various state of an illness specific aims.According to the various state of an illness, in described various prescriptions, can also add suitable leaf fat and Semen Tritici aestivi flour, utilize this prescription treatment hepatitis B to receive reasonable effect.
Chinese patent medicine-the hepatitis restoration pill of treatment hepatitis of the present invention is that the inventor is on the basis of secret prescription handed down in the family from generation to generation, consult a large amount of Gus, modern Chinese and foreign documents, to the treatment hepatopathy carry out repeated screening through the proved recipe medicine, and add through modern pharmacology and clinical research confirmation suppressing and removing hepatitis virus, adjust immune function of human body, recover liver form and function, control hepatic fibrosis and canceration truly have the Chinese medicine component of curative effect, concoct through science processing to form.
Through clinical observation, hepatitis restoration pill has strengthening body resistance and dispelling evil, adjusts the human immunologic function, effects such as inhibition and removing hepatitis virus, depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling.After taking, remarkable to the hepatitis symptom control action, good effect, short treating period, instant effect, the cure rate height is difficult for recurrence, confirms that through clinical observation its effective percentage is 96%.Its course of treatment is the shortest to be 15 days, and patient's every index after treating all reaches arm's length standard, is one of optimal drug for the treatment of at present hepatitis.
According to incomplete statistics, from January 1,1 day to 1999 January in 1989, through 2000 routine hepatitis with hepatitis restoration pill for curing of the present invention, hepatitis A patient's 800 examples are treated recovery from illness 800 examples on the 15th, cure rate 100%.Hepatitis B patient 1000 examples, positive 1000 examples of HBSAg, 425 examples of turning out cloudy, negative conversion rate 42.5%; Positive 600 examples of HBeAg, 400 examples of turning out cloudy, negative conversion rate 66.6%; Unusual 500 examples of glutamate pyruvate transaminase (SGPT) are treated and were recovered normal 480 examples in month, account for 96%.Hepatitis sx or disappearance person account for 98%.
Attached model case:
(1) king so-and-so, the man, 32 years old, chemical plant, Puyang County worker, first visit on May 20 in 1989 is an acute icterohepatitisshock, HBSAg, HBeAg, anti--three positives of HBC, GBT-360u, TTT-18u, icteric index 39.Through taking the hepatitis restoration pill for curing, on June 10th, 89 checked, and HBeAg turns out cloudy, GBT, and TTT, the icteric index full recovery is normal.Continue clothes to check on July 10th, 89, HBSAg, anti--HBC turns out cloudy, and is anti--the HBS positive.Stable curative effect, once repeatedly check was anti--the HBS positive, did not see recurrence so far.
(2) Lee so-and-so, the man, 46 years old, the cadre of Jiaozuo City agricultural bank suffered from hepatitis B 4 years, once used interferon therapy three months invalid.The first visit in 20, of 96 on JIUYUE is a great three positive, and through taking the hepatitis restoration pill for curing one month, HBeAg turns out cloudy, and treats three checks course of treatment, HBSAg, and anti--HBC turns out cloudy, and is anti--the HBS positive, do not see recurrence so far.
(3) Liu so-and-so, woman, 52 years old, Dongming, Shandong Province county three spring months township peasant suffered from hepatitis B 8 years, and first visit on March 5 in 92 year is a great three positive, B ultrasonic shows cirrhotic ascites, through taking the check in three months of hepatitis restoration pill for curing, HBSAg, HBeAg turns out cloudy, anti--HBC turns out cloudy, and is anti--the HBS positive, and B ultrasonic shows that the liver form is normal substantially, no ascites is not seen recurrence so far.
Claims (4)
1. medicine for the treatment of hepatitis is characterized in that it mainly being that raw material by following weight portion is made: Herba Hedyotidis Diffusae 10-30 part, Herba Taraxaci 10-30 part; Rhizoma Imperatae 10-30 part; Spica Prunellae 10-20 part, Herba Commelinae 15-30 part, Herba Andrographis 6-20 part; Fructus Citri Sarcodactylis 5-15 part; Rhizoma Polygoni Cuspidati 10-30 part, Radix Glycyrrhizae 2-10 part, Radix Salviae Miltiorrhizae 9-15 part; Semen Persicae 6-10 part; Radix Angelicae Sinensis 5-10 part, Fructus Schisandrae Chinensis 3-12 part, Cordyceps 3-10 part; Radix Astragali 10-20 part; Fructus Jujubae 10-35 part, Radix Notoginseng 2-5 part, Ganoderma 1.5-3 part; Calculus Bovis 0.15-0.5 part, Melanteritum 5-20 part.
2. medicine as claimed in claim 1 is characterized in that it mainly being that raw material by following row weight portion is made: Herba Hedyotidis Diffusae 12g, Herba Taraxaci 15g, Rhizoma Imperatae 15g; Spica Prunellae 10g, Herba Commelinae 15g, Herba Andrographis 9g, Fructus Citri Sarcodactylis 5g; Rhizoma Polygoni Cuspidati 15g, Radix Glycyrrhizae 5g, Radix Salviae Miltiorrhizae 12g, Semen Persicae 6g; Radix Angelicae Sinensis 9g, Fructus Schisandrae Chinensis 3g, Cordyceps 4g; Radix Astragali 10g, Fructus Jujubae 30g, Radix Notoginseng 3g; Ganoderma 2g, Calculus Bovis 0.2g, Melanteritum 10g.
3. medicine as claimed in claim 1 or 2 is characterized in that it is pill, powder, sublimed preparation or capsule.
4. as any one described medicine of claim 1-3, it is characterized in that it also contains leaf fat and wheat flour.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99100650A CN1086129C (en) | 1999-02-11 | 1999-02-11 | Hepatitis restoration pill |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99100650A CN1086129C (en) | 1999-02-11 | 1999-02-11 | Hepatitis restoration pill |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1231916A CN1231916A (en) | 1999-10-20 |
| CN1086129C true CN1086129C (en) | 2002-06-12 |
Family
ID=5270123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99100650A Expired - Fee Related CN1086129C (en) | 1999-02-11 | 1999-02-11 | Hepatitis restoration pill |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1086129C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1086300C (en) * | 1999-11-05 | 2002-06-19 | 汪怀元 | Prescription for treating hepatism |
| CN1318050C (en) * | 2002-06-10 | 2007-05-30 | 谢邦和 | Traditional Chinese medicine preparation for treating hepatitis B and preparation method thereof |
| CN100337658C (en) * | 2005-06-09 | 2007-09-19 | 北京四环科宝制药有限公司 | Chinese medicine composition for treating cold anemopyretic syndrome, and its preparing method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1171257A (en) * | 1996-07-19 | 1998-01-28 | 郑先兵 | Chinese-herbal medicine for curing hepatitis B and its preparing process |
| CN1176123A (en) * | 1996-02-15 | 1998-03-18 | 邵阳县中医院 | Medicine for chronic hepatitis B and its preparation |
-
1999
- 1999-02-11 CN CN99100650A patent/CN1086129C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1176123A (en) * | 1996-02-15 | 1998-03-18 | 邵阳县中医院 | Medicine for chronic hepatitis B and its preparation |
| CN1171257A (en) * | 1996-07-19 | 1998-01-28 | 郑先兵 | Chinese-herbal medicine for curing hepatitis B and its preparing process |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1231916A (en) | 1999-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1044974C (en) | Anti- hepatitis B preparation | |
| CN1255181C (en) | Preparation of medicinal composition for nourishing | |
| CN1243743A (en) | Medicine for treating chronic hepatism and its preparing process | |
| CN1245173C (en) | Medicine composition for treating liver fibrillation and liver cirrhosis and its prepn process | |
| CN1539441A (en) | Compounded medicine for anti pathogeny and immunoenhancement | |
| CN1056755C (en) | Medicine of curing hepatitis | |
| CN1063954C (en) | Chinese patent medicine-powder preparation for curing hepatitis B | |
| CN1086129C (en) | Hepatitis restoration pill | |
| CN1052889C (en) | Chinese proprietary for curing hepatitis | |
| CN1171615C (en) | Chinese medicine prepn for treating fatty liver and obesity | |
| CN1066628C (en) | Medicine for chronic hepatitis B and its preparation | |
| CN101036779A (en) | Composite medicine for treating hepatopathy and its preparing process | |
| CN1051471C (en) | A kind of pharmaceutical composition for treating osteoporosis | |
| CN1060379C (en) | Chines medicine for treating vitiligo and preparation method thereof | |
| CN1903276A (en) | Medicinal composition for treating hepatitis B | |
| CN1298362C (en) | Compound Chinese medicine prepn for treating pulvic infection and its prepn process | |
| CN1217204A (en) | Medicine for nourishing muscle and recovering physical strength, and preparation method therefor | |
| CN1453014A (en) | Chinese medicine prepn for preventing fibrillated liver and treating hepatocirrhosis | |
| CN1136939A (en) | Chinese drugs for curing hepatitis B | |
| CN1195541C (en) | Medicine combination for treating chronic hepatitis B | |
| CN1130529A (en) | Aizikangfuning-Chinese patent drug for treating AIDS and preparing process thereof | |
| CN1253017A (en) | Medicine for treating appendicitis | |
| CN1286483C (en) | Chinese traditional drug pills capable of protecting liver, resisting hepatic fibrosis and expelling toxins | |
| CN1179953A (en) | Complete set of Chinese medicine preparations for curing hepatitis B | |
| CN1340353A (en) | Orally-applied medicine for treating hepatism and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |